Thank you for your interest in Freespira, a pilot program made available by Harvard Pilgrim Health Care. Due to high demand, at this time we have filled all allotted pilot treatments.
Please know we are working with Harvard Pilgrim to expand the program. 
If you have further questions or wish to express your interest in Freespira, please contact Harvard Pilgrim Health Care Member Services at the number on your member ID card.
Freespira_Flag_logo_WHITE_Hrz
1. See Kaplan et al., https://doi.org/10.1007/s10484-020-09465-0
2. See Ostacher et al., https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553693/

Coaches do not provide clinical assessments, recommendations, and/or diagnoses.

Freespira is indicated (FDA-cleared) as an adjunctive treatment of symptoms associated with panic disorder, panic attacks and/or PTSD in patients 18 and older. 

*Freespira, Inc. is the maker of the Freespira treatment. Freespira, Inc. is a separate entity from Harvard Pilgrim Health Care. Harvard Pilgrim Health Care is offering Freespira treatment at no additional cost as a pilot program available to eligible commercial fully-insured Harvard Pilgrim Health Care members and their dependents aged 18 and older. Eligibility is determined by a symptom assessment and program availability is limited. Program and services subject to change. Freespira is a pilot program offered by Harvard Pilgrim and can end at any time.